These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1191 related articles for article (PubMed ID: 31928355)

  • 21. Novel delivery methods bypassing the blood-brain and blood-tumor barriers.
    Hendricks BK; Cohen-Gadol AA; Miller JC
    Neurosurg Focus; 2015 Mar; 38(3):E10. PubMed ID: 25727219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current Development of Glioblastoma Therapeutic Agents.
    Wang Z; Peet NP; Zhang P; Jiang Y; Rong L
    Mol Cancer Ther; 2021 Sep; 20(9):1521-1532. PubMed ID: 34172531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overcoming Barriers in Glioblastoma-Advances in Drug Delivery Strategies.
    Ter Linden E; Abels ER; van Solinge TS; Neefjes J; Broekman MLD
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
    Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
    Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducing a Transient Increase in Blood-Brain Barrier Permeability for Improved Liposomal Drug Therapy of Glioblastoma Multiforme.
    Lundy DJ; Lee KJ; Peng IC; Hsu CH; Lin JH; Chen KH; Tien YW; Hsieh PCH
    ACS Nano; 2019 Jan; 13(1):97-113. PubMed ID: 30532951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.
    Sarkaria JN; Hu LS; Parney IF; Pafundi DH; Brinkmann DH; Laack NN; Giannini C; Burns TC; Kizilbash SH; Laramy JK; Swanson KR; Kaufmann TJ; Brown PD; Agar NYR; Galanis E; Buckner JC; Elmquist WF
    Neuro Oncol; 2018 Jan; 20(2):184-191. PubMed ID: 29016900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug delivery approaches for the treatment of glioblastoma multiforme.
    Fakhoury M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential of exosomes as a new therapeutic strategy for glioblastoma.
    Cunha Silva L; Branco F; Cunha J; Vitorino C; Gomes C; Carrascal MA; Falcão A; Miguel Neves B; Teresa Cruz M
    Eur J Pharm Biopharm; 2024 Oct; 203():114460. PubMed ID: 39218361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymeric nanoparticles for drug delivery in glioblastoma: State of the art and future perspectives.
    Madani F; Esnaashari SS; Webster TJ; Khosravani M; Adabi M
    J Control Release; 2022 Sep; 349():649-661. PubMed ID: 35878729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New therapeutic strategies regarding endovascular treatment of glioblastoma, the role of the blood-brain barrier and new ways to bypass it.
    Peschillo S; Caporlingua A; Diana F; Caporlingua F; Delfini R
    J Neurointerv Surg; 2016 Oct; 8(10):1078-82. PubMed ID: 26541791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in brain tumor therapy: application of electrospun nanofibers.
    Norouzi M
    Drug Discov Today; 2018 Apr; 23(4):912-919. PubMed ID: 29499377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
    Drapeau A; Fortin D
    Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier.
    Wadhwa K; Chauhan P; Kumar S; Pahwa R; Verma R; Goyal R; Singh G; Sharma A; Rao N; Kaushik D
    Oncol Res; 2024; 32(5):877-897. PubMed ID: 38686045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities.
    Gupta T; Sahoo RK; Singh H; Katke S; Chaurasiya A; Gupta U
    AAPS PharmSciTech; 2023 Apr; 24(4):102. PubMed ID: 37041350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.
    Yang ZZ; Gao W; Liu YJ; Pang N; Qi XR
    Mol Pharm; 2017 Apr; 14(4):1012-1022. PubMed ID: 28252970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood-brain barrier and blood-brain tumor barrier penetrating peptide-drug conjugate as targeted therapy for the treatment of lung cancer brain metastasis.
    Zheng MZ; Yang ZQ; Cai SL; Zheng LT; Xue Y; Chen L; Lin J
    Lung Cancer; 2024 Oct; 196():107957. PubMed ID: 39303402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomedicine for brain cancer.
    Quader S; Kataoka K; Cabral H
    Adv Drug Deliv Rev; 2022 Mar; 182():114115. PubMed ID: 35077821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach.
    Agarwal S; Muniyandi P; Maekawa T; Kumar DS
    Int J Pharm; 2018 Nov; 551(1-2):339-361. PubMed ID: 30236647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penetrating the Blood-Brain Barrier by Self-Assembled 3D DNA Nanocages as Drug Delivery Vehicles for Brain Cancer Therapy.
    Tam DY; Ho JW; Chan MS; Lau CH; Chang TJH; Leung HM; Liu LS; Wang F; Chan LLH; Tin C; Lo PK
    ACS Appl Mater Interfaces; 2020 Jul; 12(26):28928-28940. PubMed ID: 32432847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.